Electrocore Inc (ECOR) Stock Price, Quote & News

Company Profile

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It...

Industry: Medical Devices

Sector: Healthcare

Phone: 888 903 2673

Fax: 973 290 9171

Website: www.electrocore.com

Address:

200 Forge Way, Suite 205, Rockaway, United States

Trekingirl Sep. 22 at 7:29 PM

$ECOR Why have we doubled in the last 6 months? We're not expected to see positive EBITDA for another year, negative earnings per share and have limited cash on hand. Long-term shareholder and bullish for the long haul but something doesn't feel right at the moment. Thoughts anyone?

0 · Reply

Yingtrader7 Sep. 22 at 4:31 PM

$NSYS unbelievable that $ECOR

0 · Reply

ItsAllAboutBeingFirst Sep. 22 at 3:43 PM

$AIRS $ECOR $OBIO $OPEN

0 · Reply

Yingtrader7 Sep. 22 at 2:01 PM

$NSYS the real winner was $ECOR

0 · Reply

ItsAllAboutBeingFirst Sep. 22 at 1:52 PM

$AIRS $ECOR $OBIO - keep making new highs

0 · Reply

taxplanr Sep. 22 at 1:42 PM

Chairman Thomas Errico buys more shares $ECOR https://investor.electrocore.com/node/12356/html

1 · Reply

Yingtrader7 Sep. 21 at 8:38 PM

$NSYS OH BTW did you see $ECOR chart lately .follow the money

0 · Reply

taxplanr Sep. 18 at 1:47 PM

$ECOR new co-CEO buys more shares https://investor.electrocore.com/node/12351/html

0 · Reply

Yingtrader7 Sep. 17 at 1:45 PM

$NSYS ok boys and girls $ECOR is putting us to shame. cmon

0 · Reply

EvilUrges Sep. 16 at 8:55 PM

$ECOR dang what is going on ?

0 · Reply

electroCore to Participate at H.C. Wainwright Global Investment Conference

2026-09-09T12:15:56.000Z - 13 days ago

electroCore appoints Joshua Lev, Mike Fox as co-CEOs

Sep 9, 2026, 8:00 AM EDT - 13 days ago

electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers

Sep 8, 2026, 9:00 AM EDT - 14 days ago

electroCore Transcript: AGM 2026

Aug 25, 2026, 8:00 AM EDT - 4 weeks ago

electroCore's Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards

2026-08-06T21:16:46.000Z - 6 weeks ago

electroCore raises FY26 revenue view to up over 30% from up 30%

2026-08-06T21:10:36.000Z - 6 weeks ago

electroCore reports Q2 EPS (33c) vs. (44c) last year

Aug 6, 2026, 4:30 PM EDT - 6 weeks ago

electroCore Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 6 weeks ago

electroCore Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 6 weeks ago

electroCore Earnings release: Q2 2026

Aug 6, 2026, 4:05 PM EDT - 6 weeks ago

electroCore Announces Second Quarter 2026 Financial Results

2026-08-04T16:35:17.000Z - 7 weeks ago

electroCore could report ‘conservative’ guidance with Q2, says H.C. Wainwright

Aug 3, 2026, 8:00 AM EDT - 7 weeks ago

electroCore to Participate in Upcoming Investor Conferences

Aug 1, 2026, 8:00 AM EDT - 7 weeks ago

electroCore Slides: Corporate presentation

Jul 30, 2026, 8:00 AM EDT - 7 weeks ago

electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026

Jul 20, 2026, 8:00 AM EDT - 2 months ago

electroCore Proxy statement: Proxy filing

2026-07-16T13:36:51.000Z - 2 months ago

electroCore announces publication of review on vagus nerve stimulation

Jul 16, 2026, 8:00 AM EDT - 2 months ago

New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation

Jun 23, 2026, 1:30 PM EDT - 3 months ago

electroCore Transcript: IAccess Alpha Virtual Best Ideas Summer Investment Conference 2026

Jun 17, 2026, 1:30 PM EDT - 3 months ago

electroCore Transcript: Planet MicroCap Las Vegas 2026

Jun 17, 2026, 8:00 AM EDT - 3 months ago

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Jun 9, 2026, 8:00 AM EDT - 3 months ago

Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery

2026-06-02T16:33:58.000Z - 3 months ago

electroCore management to meet with Maxim

Jun 2, 2026, 8:00 AM EDT - 3 months ago

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

May 18, 2026, 1:30 PM EDT - 4 months ago

electroCore Transcript: 16th Annual LD Micro Invitational Conference

2026-05-13T14:31:06.000Z - 4 months ago

electroCore Quell study shows fibromyalgia pain reduction

May 13, 2026, 8:00 AM EDT - 4 months ago

electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia

May 8, 2026, 8:00 PM EDT - 4 months ago

electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026

2026-05-07T19:32:48.000Z - 4 months ago

electroCore price target lowered to $19.85 from $22 at Ladenburg

2026-05-07T00:30:12.000Z - 4 months ago

electroCore reports Q1 EPS (59c) vs. (47c) last year

2026-05-07T00:30:04.000Z - 4 months ago

electroCore backs FY26 revenue view up 30%

May 6, 2026, 4:30 PM EDT - 4 months ago

electroCore Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 4 months ago

electroCore Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 4 months ago

electroCore Earnings release: Q1 2026

May 6, 2026, 4:05 PM EDT - 4 months ago

electroCore Announces First Quarter 2026 Financial Results

Apr 30, 2026, 8:31 AM EDT - 4 months ago

Ecora Royalties PLC to Present at the Precious Metals & Critical Minerals Virtual Investor Conference May 6th

Apr 29, 2026, 8:00 AM EDT - 4 months ago

electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 2026

Apr 28, 2026, 8:00 AM EDT - 4 months ago

electroCore to Present at the Market Movers Investor Summit on May 5, 2026

Apr 23, 2026, 8:00 AM EDT - 5 months ago

electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation

Apr 8, 2026, 8:00 AM EDT - 5 months ago

electroCore to Participate in the 25th Annual Needham Virtual Healthcare Conference

2026-04-07T12:35:06.000Z - 5 months ago

electroCore enrolls first patients in gammaCore device clinical study

Apr 7, 2026, 8:00 AM EDT - 5 months ago

electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD

Apr 1, 2026, 8:00 AM EDT - 5 months ago

electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD

2026-03-30T12:21:22.000Z - 5 months ago

electroCore issued two new U.S. patents

Mar 30, 2026, 8:00 AM EDT - 5 months ago

electroCore Expands Intellectual Property Portfolio

Mar 25, 2026, 7:00 AM EDT - 6 months ago

electroCore Slides: Corporate presentation

Mar 19, 2026, 4:30 PM EDT - 6 months ago

electroCore Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 6 months ago

electroCore Annual report: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 6 months ago

electroCore Earnings release: Q4 2025

Mar 19, 2026, 4:05 PM EDT - 6 months ago

electroCore Announces Full Year 2025 Financial Results and Organizational Changes

Mar 10, 2026, 8:00 AM EDT - 6 months ago

electroCore to Participate at the 38th Annual Roth Conference

Mar 9, 2026, 8:00 AM EDT - 6 months ago

electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026

2026-01-26T11:20:09.000Z - 7 months ago

electroCore price target lowered to $18 from $25 at H.C. Wainwright

2026-01-21T13:20:50.000Z - 8 months ago

electroCore announces Acacia Clinics, Vagus Nerve study gammaCore Sapphire

Jan 21, 2026, 8:00 AM EST - 8 months ago

Acacia Clinics and Vagus Nerve Society Conduct Study Using electroCore's gammaCore Sapphire for Adjunctive Treatment of Symptoms Associated with Post-Traumatic Stress Disorder (“PTSD”)

2026-01-20T13:25:20.000Z - 8 months ago

electroCore sees Q4 revenue $9M-$9.2M, consensus $9.02M

Jan 20, 2026, 8:00 AM EST - 8 months ago

electroCore Provides Preliminary Full-Year 2025 Business Update; Expects ~26% Revenue Growth to ~$31.8–$32.0 Million

2025-12-02T13:15:12.000Z - 9 months ago

electroCore announces publication of peer reviewed paper on TAC-STIM tVNS

Dec 2, 2025, 8:00 AM EST - 9 months ago

TAC-STIM Demonstrates Significant Performance Improvements in Active-Duty United States Air Force Airmen

Nov 10, 2025, 4:05 PM EST - 10 months ago

electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

2025-11-05T22:50:15.000Z - 10 months ago

electroCore raises FY25 revenue outlook to $31.5M-$32.5M from $30M

2025-11-05T22:40:36.000Z - 10 months ago

electroCore reports Q3 EPS (40c), consensus (40c)

Nov 5, 2025, 4:30 PM EST - 10 months ago

electroCore Earnings Call Transcript: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

electroCore Earnings release: Q3 2025

Nov 5, 2025, 4:30 PM EST - 10 months ago

electroCore Quarterly report: Q3 2025

Nov 5, 2025, 4:05 PM EST - 10 months ago

electroCore Announces Third Quarter 2025 Financial Results

Oct 23, 2025, 8:11 AM EDT - 11 months ago

electroCore to Announce Third Quarter September 30, 2025 Financial Results on Wednesday, November 5, 2025

2025-10-03T21:20:15.000Z - 11 months ago

electroCore files to sell 763K shares of common stock for holders

Oct 3, 2025, 4:05 PM EDT - 11 months ago

electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

Oct 3, 2025, 8:00 AM EDT - 11 months ago

electroCore Registration statement: Registration Filing

2025-09-30T12:21:54.000Z - 11 months ago

electroCore announces publication on gammaCore nVNS

Sep 30, 2025, 8:00 AM EDT - 11 months ago

gammaCore® Non-Invasive Vagus Nerve Stimulation (nVNS) as an Adjunctive Treatment Associated with Improvements in Persistent Post-Concussion Symptoms

Sep 29, 2025, 8:00 AM EDT - 11 months ago

electroCore Announces Reimbursement Approval for gammaCore™ by RIZIV/INAMI in Belgium

Sep 22, 2025, 8:00 AM EDT - 1 year ago

electroCore's Truvaga™ Plus Named “Best Relaxation Gadget” in Esquire's 2025 Sleep Awards

Sep 5, 2025, 8:00 AM EDT - 1 year ago

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board

Sep 4, 2025, 8:00 AM EDT - 1 year ago

electroCore Partners with iHeartRadio and Former New York Jets Star Linebacker Greg Buttle to Champion Better Sleep and Stress Relief

Sep 3, 2025, 8:00 AM EDT - 1 year ago

electroCore Appoints Elena Bonfiglioli to Board of Directors

Aug 12, 2025, 8:00 AM EDT - 1 year ago

electroCore Names Kelly Benning, Accomplished Healthcare Executive, as SVP of Truvaga

Aug 6, 2025, 4:30 PM EDT - 1 year ago

electroCore Earnings Call Transcript: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

electroCore Quarterly report: Q2 2025

Aug 6, 2025, 4:30 PM EDT - 1 year ago

electroCore Earnings release: Q2 2025

Aug 6, 2025, 4:05 PM EDT - 1 year ago

electroCore Announces Second Quarter 2025 Financial Results

Aug 5, 2025, 8:00 AM EDT - 1 year ago

electroCore Appoints James C. Theofilos to the Board of Directors

Jul 23, 2025, 8:00 AM EDT - 1 year ago

electroCore to Announce Second Quarter June 30, 2025 Financial Results on Wednesday, August 6, 2025

Jul 18, 2025, 8:00 AM EDT - 1 year ago

electroCore Registration statement: Registration Filing

Jul 17, 2025, 8:00 AM EDT - 1 year ago

electroCore Proxy statement: Proxy Filing

May 9, 2025, 7:00 AM EDT - 1 year ago

electroCore Slides: Corporate Presentation

May 7, 2025, 4:30 PM EDT - 1 year ago

electroCore Earnings Call Transcript: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

electroCore Quarterly report: Q1 2025

May 7, 2025, 4:30 PM EDT - 1 year ago

electroCore Earnings release: Q1 2025

May 7, 2025, 4:05 PM EDT - 1 year ago

electroCore Announces First Quarter 2025 Financial Results

May 2, 2025, 8:00 AM EDT - 1 year ago

electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies

May 1, 2025, 8:00 AM EDT - 1 year ago

electroCore's Truvaga™ Now Works with the Apple Health app

Apr 30, 2025, 8:00 AM EDT - 1 year ago

electroCore to Announce First Quarter March 31, 2025 Financial Results on Wednesday, May 7, 2025

Apr 23, 2025, 4:30 PM EDT - 1 year ago

electroCore Transcript: Planet MicroCap Showcase: VEGAS 2025

Apr 17, 2025, 8:00 AM EDT - 1 year ago

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Shown to be Effective in Treating Concussive Symptoms Associated with Mild Traumatic Brain Injuries

Apr 16, 2025, 8:00 AM EDT - 1 year ago

electroCore to Participate at the Planet MicroCap Showcase

Apr 10, 2025, 2:15 PM EDT - 1 year ago

electroCore Transcript: 24th Annual Needham Virtual Healthcare Conference

Apr 3, 2025, 8:00 AM EDT - 1 year ago

electroCore Named One of The Americas' Fastest Growing Companies by the Financial Times

Apr 1, 2025, 8:00 AM EDT - 1 year ago

electroCore to Participate at the Needham Virtual Healthcare Conference

Mar 31, 2025, 8:00 AM EDT - 1 year ago

electroCore Extends VA Contract for Five Years

Trekingirl Sep. 22 at 7:29 PM

0 · Reply

Yingtrader7 Sep. 22 at 4:31 PM

$NSYS unbelievable that $ECOR

0 · Reply

ItsAllAboutBeingFirst Sep. 22 at 3:43 PM

$AIRS $ECOR $OBIO $OPEN

0 · Reply

Yingtrader7 Sep. 22 at 2:01 PM

$NSYS the real winner was $ECOR

0 · Reply

ItsAllAboutBeingFirst Sep. 22 at 1:52 PM

$AIRS $ECOR $OBIO - keep making new highs

0 · Reply

taxplanr Sep. 22 at 1:42 PM

Chairman Thomas Errico buys more shares $ECOR https://investor.electrocore.com/node/12356/html

1 · Reply

Yingtrader7 Sep. 21 at 8:38 PM

$NSYS OH BTW did you see $ECOR chart lately .follow the money

0 · Reply

taxplanr Sep. 18 at 1:47 PM

$ECOR new co-CEO buys more shares https://investor.electrocore.com/node/12351/html

0 · Reply

Yingtrader7 Sep. 17 at 1:45 PM

$NSYS ok boys and girls $ECOR is putting us to shame. cmon

0 · Reply

EvilUrges Sep. 16 at 8:55 PM

$ECOR dang what is going on ?

0 · Reply

Trekingirl Sep. 11 at 3:48 PM

$ECOR October 2nd is rapidly approaching. Do you think litigation will be successful? It's obvious Pulsetto infringed on our patent. We havethe patent. We have the APEX. Private equity crying because they got their hand caught in the cookie jar stealing. Can't wait till they get the real ass whooping they deserve.

1 · Reply

Yingtrader7 Sep. 11 at 2:02 PM

$NSYS Our Peer $ECOR seems to doing fantastic.

0 · Reply

BioTuesdays Sep. 1 at 1:05 PM

$ECOR has built a commercial-stage bioelectric medicine and wellness platform around non-invasive neuromodulation, with applications spanning prescription therapeutics, military human performance, and direct-to-consumer wellness. The company’s non-invasive vagus nerve stimulation (nVNS) uses electrical signals delivered through the skin of the neck to stimulate the vagus nerve without surgery or an implanted device. https://biotuesdays.com/2026/09/01/electrocore-builds-on-its-neuromodulation-platform-to-drive-its-next-phase-of-growth/

0 · Reply

FrostyOrbit Aug. 30 at 10:34 PM

$ECOR Q2 revenue: $9.5M, +28% YoY...

0 · Reply

EvilUrges Aug. 26 at 7:24 PM

$ECOR I’ve been seeing truvaga ads on Facebook. Mostly from biohacker, influencer types.

0 · Reply

taxplanr Aug. 26 at 1:37 PM

$ECOR apparently CFO Joshua Lev needs cash? But no one else https://investor.electrocore.com/node/12276/html

0 · Reply

prismmarketview Aug. 25 at 7:59 PM

$ECOR — Truvaga wins 2026 "Best Luxury Biohacking & Longevity Brand in the USA" from Luxury Lifestyle Awards, recognizing its nVNS (non-invasive vagus nerve stimulation) tech for stress, focus, and sleep. Brand-building win, not a clinical or regulatory milestone — award doesn't independently validate product performance. Watch Truvaga revenue growth, margins, and customer acquisition costs as the real signal. $ECOR #MedTech #Wellness https://prismmarketview.com/electrocores-truvaga-wins-2026-luxury-biohacking-and-longevity-brand-award/

0 · Reply

EvilUrges Aug. 19 at 8:08 PM

$ECOR damn what happened at the end of the day

0 · Reply

Mudloaf Aug. 17 at 11:52 AM

$ECOR Ericco bought more at $9.85 https://www.sec.gov/Archives/edgar/data/1560258/000149315226038600/xslF345X06/ownership.xml

0 · Reply

Mudloaf Aug. 15 at 3:59 PM

$ECOR biggest potential surprise here is a potential settlement in the pulsetto litigation. No idea if / when it comes, but they’ve been in mediation for months and can’t discuss it publicly. So the potential for a big surprise is there.

0 · Reply

BMG144 Aug. 13 at 5:59 PM

$ECOR Stick with this one, people. I think we can hit 20 on the next earnings report.

0 · Reply

taxplanr Aug. 12 at 2:45 PM

$ECOR made it through https://www.instagram.com/p/DbYeLsikWQ_/?img_index=9&igsh=NnByMDg3M2J6cnQ2

0 · Reply

Market Cap	108.15M
Revenue (ttm)	32.03M
Net Income (ttm)	-13.97M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-43.62%
Debt to Equity Ratio	-2.07

Volume	126,200
Avg Vol	84,704
Day's Range	N/A - N/A
Shares Out	9.02M
Stochastic %K	90%
Beta	1.00
Analysts	Strong Sell
Price Target	$18.96